nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.06.2017 | Image of the Month

Diffuse ¹⁸F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 9/2017

Einloggen, um Zugang zu erhalten

Excerpt

…

Wingerchuk DM, Banwell B, Bennett JL, Cabre P, Carroll W, Chitnis T, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177–89. doi:10.1212/wnl.0000000000001729.CrossRefPubMedPubMedCentral

Weinshenker BG, Wingerchuk DM. Neuromyelitis spectrum disorders. Mayo Clin Proc. 2017;92(4):663–79. doi:10.1016/j.mayocp.2016.12.014.CrossRefPubMed

Oyama H, Miwa S, Noda T, Sobajima A, Kito A, Maki H, et al. Neuromyelitis optica spectrum disorder: 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography findings--case report. Neurol Med Chir. 2012;52(10):769–73.CrossRef

Kawai M, Shimizu F, Omoto M, Ogasawara J-I, Takahashi T, Kanda T. Neuromyelitis optica shows hypermetabolism in 18-fluorodeoxyglucose positron emission tomography. Clin Exp Neuroimmunol. 2012;3(2):85–7. doi:10.1111/j.1759-1961.2011.00026.x.CrossRef

Titel: Diffuse 18F-FDG uptake throughout the spinal cord in the acute phase of Neuromyelitis Optica Spectrum disorder
Publikationsdatum: 01.06.2017
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 9/2017
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-017-3735-z

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 9/2017

18F-fluorodeoxyglucose positron emission tomography in the diagnosis of malignancy in patients with paraneoplastic neurological syndrome: a systematic review and meta-analysis

Inter-heterogeneity and intra-heterogeneity of αvβ3 in non-small cell lung cancer and small cell lung cancer patients as revealed by 68Ga-RGD2 PET imaging

Diagnosis of recurrent prostate cancer with PET/CT imaging using the gastrin-releasing peptide receptor antagonist 68Ga-RM2: Preliminary results in patients with negative or inconclusive [18F]Fluoroethylcholine-PET/CT

Comparison of FDG-PET/CT and contrast-enhanced CT for monitoring therapy response in patients with metastatic breast cancer

Highlights lecture EANM 2016: “Embracing molecular imaging and multi-modal imaging: a smart move for nuclear medicine towards personalized medicine”

Individualised 177Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry